COR
Cencora, Inc.
Overview
Cencora distributes brand-name, generic, and specialty pharmaceuticals, over-the-counter healthcare products, and medical supplies to hospitals, pharmacies, clinics, physicians, and veterinarians across the U.S. and select global markets.
Cencora, Inc is a Healthcare company operating in Medical Distribution with a $52.78B market cap.
Most recent reported earnings: Q2 FY2026 (Aug 4, 2026).
21 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from Unknown source, 2026-06-21.
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
- Q1 FY2026Earnings2026-02-0421 Q&A exchanges
- Q4 FY2025Earnings2025-11-0511 Q&A exchanges
- Q3 FY2025Earnings2025-08-0613 Q&A exchanges
- Q2 FY2025Earnings2025-05-0711 Q&A exchanges
- Q1 FY2025Earnings2025-02-0514 Q&A exchanges
- Q4 FY2024Earnings2024-11-0612 Q&A exchanges
- Q3 FY2024Earnings2024-07-3114 Q&A exchanges
- Q2 FY2024Earnings2024-05-0110 Q&A exchanges
- Q1 FY2024Earnings2024-01-3111 Q&A exchanges
- Q4 FY2023Earnings2023-11-049 Q&A exchanges
- Q3 FY2023Earnings2023-08-0210 Q&A exchanges
- Q2 FY2023Earnings2023-05-029 Q&A exchanges
- Q1 FY2023Earnings2023-02-0111 Q&A exchanges
- Q4 FY2022Earnings2022-11-039 Q&A exchanges
- Q3 FY2022Earnings2022-08-0310 Q&A exchanges
- Q2 FY2022Earnings2022-05-048 Q&A exchanges
- Q1 FY2022Earnings2022-02-0213 Q&A exchanges
- Q4 FY2021Earnings2021-11-049 Q&A exchanges
- Q3 FY2021Earnings2021-10-2845 Q&A exchanges
- Q2 FY2021Earnings2021-07-2928 Q&A exchanges
- Q1 FY2021Earnings2021-04-2926 Q&A exchanges
History
Earnings history
- Q2 FY20262026-08-04EPS— vs $4.35—Rev— vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 2026-08-04 | — | $4.35 | — | — | — | — | EODHD |
Source: EODHD. COR reported actuals as published; sparse fields render as —.
Track Record
SampleSpoken Alpha tracks COR's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Misses consensus 10/10 quarters
SampleRepeated misses without a guidance reset suggest management is structurally optimistic relative to operating reality. Track whether next-quarter guidance is being benchmarked off the prior miss or the prior plan.
Missed in 4 of the last 4 quarters
SampleRecent misses matter more than long-window beat rate — the trailing 12 months drives the analyst model and the next-print bar.
Quarterly beats & misses
Sample| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $3.89 | $4.30 | -9.6% | -3.1% | -0.5% |
| Q4 FY2026 | $4.02 | $4.38 | -8.3% | +5.1% | +7.0% |
| Q3 FY2026 | $3.77 | $4.50 | -16.2% | -6.1% | -7.6% |
| Q2 FY2026 | $3.98 | $4.56 | -12.8% | +3.3% | +3.3% |
| Q1 FY2025 | $3.59 | $4.37 | -17.8% | -6.2% | -6.8% |
| Q4 FY2025 | $3.82 | $4.40 | -13.1% | +3.8% | +6.3% |
| Q3 FY2025 | $3.93 | $4.51 | -12.9% | -0.2% | -1.0% |
| Q2 FY2025 | $3.85 | $4.36 | -11.6% | +4.6% | +5.7% |
| Q1 FY2024 | $4.10 | $4.53 | -9.6% | -3.9% | -1.5% |
| Q4 FY2024 | $4.13 | $4.50 | -8.3% | -0.3% | -1.6% |
Guidance change history
Sample- Q1 FY2026Lowered2026-04-15
- Q4 FY2026Lowered2026-13-15
- Q3 FY2026Lowered2026-10-15
- Q2 FY2026Lowered2026-07-15
- Q1 FY2025Lowered2025-04-15
- Q4 FY2025Lowered2025-13-15
- Q3 FY2025Lowered2025-10-15
- Q2 FY2025Lowered2025-07-15
Top executives
SampleSpoken Alpha builds an accountability record per executive — how the person's own guidance, language, and reactions have evolved across every call they've appeared on. The one-liners below are illustrative placeholder data pending the deviation v1 work. Click any name for the full role timeline and call appearance history.
- Robert P MauchCEO7 mo8 callsCurrentSample
CEO since 2025 • 3/4 beats (75%) • last guidance raise Q3 FY2026
- James F ClearyCFO7 mo17 callsCurrentSample
CFO since 2025 • 3/4 beats (75%) • last guidance raise Q1 FY2026
- Lazarus KrikorianSVP & Chief Accounting Officer7 mono recorded callsCurrentSample
OTHER_C_SUITE since 2025 • 3/4 beats (75%) • last guidance raise Q2 FY2026
- Pawan VermaEVP, Chief Data & Info Officer7 mono recorded callsCurrentSample
DIVISION_HEAD since 2025 • 2/4 beats (50%) • last guidance cut Q3 FY2026
- Silvana BattagliaExecutive Vice President7 mono recorded callsCurrentSample
OTHER since 2025 • 3/4 beats (75%) • last guidance raise Q1 FY2026
- Elizabeth S CampbellExecutive Vice President7 mono recorded callsCurrentSample
OTHER since 2025 • 2/4 beats (50%) • guidance suspended Q2 FY2026
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for COR.
$ curl https://api.spokenalpha.com/v1/companies/CORFAQ
Frequently asked about COR
Where can I find Cencora, Inc.'s (COR) earnings call transcripts?
Spoken Alpha indexes COR's earnings call transcripts at https://spokenalpha.com/companies/COR. Each call links to attributed speakers and parsed analyst Q&A. Cencora, Inc.'s own investor relations page is at https://investor.cencora.com/stock-info/stock-quote/default.aspx.
When was Cencora, Inc.'s most recent earnings call?
Cencora, Inc. (COR) held its most recent earnings call on 2026-02-04, covering fiscal Q1 2026.
What sector is COR in?
Cencora, Inc. (COR) operates in the Healthcare sector (Medical Distribution industry).